Evidence map›Paper›PMID 33766079›Full record

ArticleBreast cancer research : BCR2021

Correction to: Establishing and characterizing patient-derived xenografts using pre-chemotherapy percutaneous biopsy and post-chemotherapy surgical samples from a prospective neoadjuvant breast cancer study.

Jia Yu, Bo Qin, Ann M Moyer, Jason P Sinnwell, Kevin J Thompson, John A Copland, Laura A Marlow, James L Miller, Ping Yin, Bowen Gao and 20 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Breast cancer research : BCR, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

30 authors.

Jia YuDepartment of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA.
Bo QinDepartment of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA.
Ann M MoyerDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, 55905, USA.
Jason P SinnwellDepartment of Health Sciences Research, Mayo Clinic, Rochester, MN, 55905, USA.
Kevin J ThompsonDepartment of Health Sciences Research, Mayo Clinic, Rochester, MN, 55905, USA.
John A CoplandDepartment of Cancer Biology, Mayo Clinic, Jacksonville, FL, 32224, USA.
Laura A MarlowDepartment of Cancer Biology, Mayo Clinic, Jacksonville, FL, 32224, USA.
James L MillerDepartment of Cancer Biology, Mayo Clinic, Jacksonville, FL, 32224, USA.
Ping YinDepartment of Oncology, Mayo Clinic, Rochester, MN, 55905, USA.
Bowen GaoDepartment of Surgery, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA.
Katherine Minter-DykhouseDepartment of Oncology, Mayo Clinic, Rochester, MN, 55905, USA.
Xiaojia TangDepartment of Health Sciences Research, Mayo Clinic, Rochester, MN, 55905, USA.
Sarah A McLaughlinDepartment of Surgery, Mayo Clinic, Jacksonville, FL, 32224, USA.
Alvaro Moreno-AspitiaDepartment of Hematology/Oncology, Mayo Clinic, Jacksonville, FL, 32224, USA.
Anthony SchweitzerAffymetrix, now part of Thermo Fisher Scientific, Santa Clara, CA, 95051, USA.
Yan LuAffymetrix, now part of Thermo Fisher Scientific, Santa Clara, CA, 95051, USA.
Jason HubbardAffymetrix, now part of Thermo Fisher Scientific, Santa Clara, CA, 95051, USA.
Donald W NorthfeltDepartment of Hematology/Oncology, Mayo Clinic, Scottsdale, AZ, 85259, USA.
Richard J GrayDepartment of Surgery, Mayo Clinic, Scottsdale, AZ, 85259, USA.
Katie HuntDepartment of Radiology, Mayo Clinic, Rochester, MN, 55905, USA.
Amy L ConnersDepartment of Radiology, Mayo Clinic, Rochester, MN, 55905, USA.
Vera J SumanDepartment of Health Sciences Research, Mayo Clinic, Rochester, MN, 55905, USA.
Krishna R KalariDepartment of Health Sciences Research, Mayo Clinic, Rochester, MN, 55905, USA.
James N IngleDepartment of Oncology, Mayo Clinic, Rochester, MN, 55905, USA.
Zhenkun LouDepartment of Oncology, Mayo Clinic, Rochester, MN, 55905, USA.
Daniel W VisscherDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, 55905, USA.
Richard WeinshilboumDepartment of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA.
Judy C BougheyDepartment of Surgery, Mayo Clinic, Rochester, MN, 55905, USA.
Matthew P GoetzDepartment of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA.
Liewei WangDepartment of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA. Wang.Liewei@mayo.edu.

Funding

Women's Cancer ProgramP30CA015083 · NCI · MAYO CLINIC ROCHESTER · PI Felicity Enders · 1985 to 2026
$151.3M
NCI NIH HHS P30 CA015083
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID33766079
PMCPMC7992984

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.